Safety and efficacy of up to 76 weeks 10 mg/day (high dose) bulevirtide monotherapy in compensated cirrhotics with delta hepatitis. (February 2020)

Record Type:
Journal Article
Title:
Safety and efficacy of up to 76 weeks 10 mg/day (high dose) bulevirtide monotherapy in compensated cirrhotics with delta hepatitis. (February 2020)
Main Title:
Safety and efficacy of up to 76 weeks 10 mg/day (high dose) bulevirtide monotherapy in compensated cirrhotics with delta hepatitis
Authors:
Loglio, A.
Ferenci, P.
Schlund, F.
Tham, C.Y.L.
van Bömmel, F.
Renteria, SC. Uceda
Borghi, M.
Holzmann, H.
Perbellini, R.
Trombetta, E.
Giovanelli, S.
Porretti, L.
Prati, D.
Ceriotti, F.
Lunghi, G.
Bertoletti, A.
Urban, S.
Lampertico, P.
Abstract:
Is Part Of:
Digestive and liver disease. Volume 52(2020)Supplement 1
Journal:
Digestive and liver disease
Issue:
Volume 52(2020)Supplement 1
Issue Display:
Volume 52, Issue 1 (2020)
Year:
2020
Volume:
52
Issue:
1
Issue Sort Value:
2020-0052-0001-0000
Page Start:
e28
Page End:
e29
Publication Date:
2020-02
Subjects:
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005
Journal URLs:
http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.dld.2019.12.112 ↗
Languages:
English
ISSNs:
1590-8658
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
21852.xml